Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine candidate
You Might Like
💡 newsR Knowledge: Other News Mentions
Coronavirus: Oxford University vaccine found to produce COVID-19 antibodies
Credit: euronews (in English) Duration: 02:18Published
'Very positive': UK vaccine prompts immune response in
Credit: Al Jazeera STUDIO Duration: 04:44Published
Covid-19 vaccine: "New results are very encouraging"
Credit: ODN Duration: 02:01Published
UK coronavirus vaccine shows early promise
Credit: Al Jazeera STUDIO Duration: 10:06Published
Congress MP Karti Chidambaram tests positive for coronavirus
Credit: ANI Duration: 01:00Published
New 90-minute tests for Covid-19 to be rolled out
Credit: PA - Press Association STUDIO Duration: 01:19Published
Covid-19 tests in India cross 2-crore markThe total number of tests for detection of COVID-19 has crossed the two-crore mark in India, according to the Indian Council of Medical Research (ICMR) data.
Lok Sabha MP Karti Chidambaram tests positive for Covid-19"I have just tested positive for #Covid. My symptoms are mild and as per medical advice I am under home quarantine. I would urge all those who have recently been..
Coronavirus vaccine: DCGI gives nod to Serum-Oxford for phase 2, 3 clinical trials in IndiaDCGI has allowed the Serum Institute of India to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine.
COVID-19: DCGI nod to Serum Institute of India for phase 2 and 3 human clinical trials of Oxford vaccine candidateGovernment officials told PTI that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after..
DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccineA CDSCO expert panel has sought clarifications from Serum Institute of India (SII) over its application to the DCGI seeking permission for conducting phase 2 and..
Related videos from verified sources
Related news from verified sources
Tweets about this